Recent investigations have raised significant concern regarding Wockhardt’s cough medication, specifically concerning the detection of dangerous levels of dextromethorphan and other contaminants. While the company initially maintained its commitment to standards, various incidents of unwanted outcomes, including critical impairment and even death